Onni Turpeinen

Co-Founder at Orion Oyj

Onni Turpeinen

Onni Turpeinen

Co-Founder at Orion Oyj

Biography

Mr. Onni Turpeinen was previously employed as a Co-Founder by Orion Oyj.

Overview
Career Highlights

Orion Oyj

RelSci Relationships

45

Relationships
RelSci Relationships are individuals Onni Turpeinen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Orion Oyj

Relationship likelihood: Average

Former Head-Communications at Orion Oyj

Relationship likelihood: Average

Former Head-Region Finland at Orion Oyj

Relationship likelihood: Weak

Director-Biostatistics & Support Functions at Orion Oyj

Relationship likelihood: Weak

Director, Financial Control Accounting & Reporting Administration at Orion Oyj

Relationship likelihood: Weak

Adivsor at Unleash Team Ltd

Relationship likelihood: Weak

Executive Assistant & IR Event Coordinator at Orion Oyj

Relationship likelihood: Weak

Director, Nonclinical Safety Evaluation at Orion Oyj

Relationship likelihood: Weak

Director-Pharmaceutical Sciences at Orion Oyj

Relationship likelihood: Weak

Director-Intellectual Property Rights at Orion Oyj

Relationship likelihood: Weak

Paths to Onni Turpeinen
Potential Connections via
Relationship Science
You
Onni Turpeinen
Co-Founder at Orion Oyj
Career History
Co-Founder
1917 - Prior

Orion in brief Orion as a company Orion Group operational structure Best selling products Business environment Business Divisions Line functions Operational model Strategy Partnering / Licensing Corporate Governance General Meetings of Shareholders History Values Orion Events Calendar 2013 Home / Orion / Orion in brief / Orion as a company Print Orion as a company Orion Corporation develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. Orion has been building well-being already for 95 years. Orion as a listed company Orion’s Shares A and B are quoted on the NASDAQ OMX Helsinki in the Large Cap group under the Healthcare sector heading. Trading in both of the company’s share classes commenced on 3 July 2006 under the trading codes ORNAV and ORNBV. Information on trading in the company’s shares has been available since this date. Clientele Orion’s clientele consists of healthcare service providers and professionals, such as doctors, pharmacies, hospitals, healthcare centers, clinics and laboratories. Pharmaceuticals business Pharmaceuticals account for about 95% of Orion’s net sales, of which a considerable part comes from proprietary patented pharmaceutical innovations. The core therapy areas in Orion’s product and research strategy are: central nervous system oncology and critical care respiratory medicines administered with the Easyhler device. Orion has also a large portfolio of generic, off-patent prescription medicines, hospital treatments and self-care products. These products are sold mainly in Finland, other Nordic countries, the new EU countries and Germany. In animal health, Orion has the leading market position in its home territory, the Nordic countries. The subsidiary Fermion produces active pharmaceutical ingredients for both Orion and other pharmaceutical companies. Diagnostics business Orion’s diagnostic tests are used widely around the world to help in diagnosing patients and to contribute to the follow-up of treatment. The emphasis in this product sector is on easy-to-use and rapid point-of-care tests. The leading brand is the QuikRead® CRP test for diagnosing infections.

Other Affiliations

Onni Turpeinen is affiliated with Orion Oyj

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Onni Turpeinen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Onni Turpeinen's profile does not indicate a business or promotional relationship of any kind between RelSci and Onni Turpeinen.